Learning Objectives:

1. Review the diagnosis, evaluation, and treatment of osteoporosis.
2. Evaluate the evidence for use of osteoclast inhibitors in early breast cancer and review current guidelines.
3. Understand the risks of bone loss and vertebral fractures after denosumab discontinuation and discuss sequential use of bisphosphonates to prevent these complications.